Jiangsu HengRui Medicine Co., Ltd.: all 1,057 studies

Page 10 of 11. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.

• The PK/PD Study of SHR2285 Tablets in Healthy SubjectsCompletedNCT03769831Phase 1
• A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPCTerminatedNCT03741712Phase 1/2
• SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell CancerStatus unknownNCT03732508Phase 2
• Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced MalignanciesSuspendedNCT03722186Phase 1
• Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)Status unknownNCT03711305Phase 3
• A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque PsoriasisStatus unknownNCT03710681Phase 1
• SHR-1701 in Metastatic or Locally Advanced Solid TumorsStatus unknownNCT03710265Phase 1
• Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT03707509Phase 3
• Safety, Tolerability and PK of SHR1314 in axSpACompletedNCT03704428Phase 1
• Study of SHR-1210 in Combination With Chemotherapy in Advanced Esophageal CancerCompletedNCT03691090Phase 3
• A Phase II Study in Patients With Moderate to Severe Active Crohn's DiseaseCompletedNCT03677648Phase 2
• Safety, Tolerability and PK/PD of SHR1459 in Healthy VolunteersStatus unknownNCT03668509Phase 1
• A Study of SHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLCStatus unknownNCT03668496Phase 3
• A Study of SHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLCTerminatedNCT03666728Phase 2
• Tolerance and Pharmacokinetics of SHR1459 in Patients With Recurrent Replased/Refractory Mature B Cell NeoplasmstumorStatus unknownNCT03664297Phase 1
• SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal CancerTerminatedNCT03645876Phase 2
• The PK/PD Study of SHR0532 Tablets in Healthy SubjectsStatus unknownNCT03645278Phase 1
• The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy SubjectsCompletedNCT03634436Phase 1
• A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment.Status unknownNCT03605706Phase 3
• A Phase 1 Study of SHR2554 in Subjects With Relapsed or Refractory Mature Lymphoid NeoplasmsStatus unknownNCT03603951Phase 1
• A Study to Evaluate Different Intervals Between Dosing and Feeding on the PharmacokineticsCompletedNCT03603132Phase 1
• SHR9549 in ER Positive HER2 Negative Advanced Breast CancerTerminatedNCT03596658Phase 1
• Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast CancerCompletedNCT03588091Phase 3
• A Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Severe Aplastic Anemia （SAA） PatientCompletedNCT03557099Phase 1/2
• A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate CancerActive, not recruitingNCT03520478Phase 3
• A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian CancerCompletedNCT03509636Phase 1
• A Single Dose Study of SHR0410 in Healthy Male ParticipantsCompletedNCT03493191Phase 1
• Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid TumorsStatus unknownNCT03491631Phase 1
• A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast CancerCompletedNCT03481998Phase 1/2
• Safety and Tolerability of SHR-1316 in Subjects With Advanced TumorsStatus unknownNCT03474289Phase 1
• Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque PsoriasisCompletedNCT03463187Phase 1/2
• A Phase Ⅰb Study of Remimazolam Tosylate in Healthy VolunteersCompletedNCT03444480Phase 1
• Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI EndoscopyCompletedNCT03425474Phase 3
• Safety and Tolerability of HTI-1066 in Subjects With Advanced Solid TumorsStatus unknownNCT03398720Phase 1
• SHR-1210 in Patients With Relapsed or Refractory Extranodal NK/T Cell LymphomaStatus unknownNCT03363555Phase 2
• Drug-drug Interaction Between Simvastatin and SHR3824Status unknownNCT03329118Phase 1
• Safety, Pharmacokinetics and Pharmacodynamics of Intranasal Dexmedetomidine in Healthy SubjectsStatus unknownNCT03293277Phase 1
• Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) PatientsCompletedNCT03254966Phase 2
• A Study To Test The Effect Of Apatinib On P450 EnzymesStatus unknownNCT03245307Phase 1
• Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) PatientCompletedNCT03222843Phase 3
• Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid LevelCompletedNCT03211403Phase 1
• A Trial of HTI-1090 in Subjects With Advanced Solid TumorsCompletedNCT03208959Phase 1
• A Phase 1, Study to Evaluate HTI-2088 TabletCompletedNCT03203811Phase 1
• Dose-finding and Safety Study of SHR4640 in Subjects With HyperuricemiaCompletedNCT03185793Phase 2
• The Study of SHR7390 in Combination With SHR-1210 and SHR3162 in Patients With Advanced Solid TumorsTerminatedNCT03182673Phase 1
• Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Patients With Hepatic ImpairmentStatus unknownNCT03160014Phase 1
• Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal InsufficientStatus unknownNCT03159832Phase 1
• Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 DiabetesStatus unknownNCT03159052Phase 3
• A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLCCompletedNCT03134872Phase 3
• A Trial to Evaluate Safety and Tolerability of SHR-1316 in Cancer PatientsCompletedNCT03133247Phase 1
• The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With GoutCompletedNCT03131583Phase 1
• A Study to Evaluate the Safety and Efficacy of SHR-1210, Gemcitabine and Cis-platinum by R/M NPC SubjectsCompletedNCT03121716Phase 1
• A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLCStatus unknownNCT03085069Phase 2
• Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer. (PHOEBE)Status unknownNCT03080805Phase 3
• A Study of Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer PatientsCompletedNCT03075462Phase 1
• Food-Effect and Metabolism Study in Healthy SubjectsCompletedNCT03062982Phase 1
• A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer PatientsStatus unknownNCT03026881Phase 1
• A Single Dose Study of SHR4640 in Healthy Male VolunteersCompletedNCT03015948Phase 1
• A Phase 1, Randomized, Placebo-controlled, Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Chinese Type 2 Diabetic PatientsCompletedNCT03006159Phase 1
• A Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI EndoscopyCompletedNCT03003884Phase 2
• A Study of Pyrotinib Plus Capecitabine in Patients With HER2+ Metastatic Breast CancerStatus unknownNCT02973737Phase 3
• Phase I Study of SHR7390 in Patients With Advanced Solid TumorsStatus unknownNCT02968485Phase 1
• A Study of SHR-1314 in Healthy SubjectsCompletedNCT02934412Phase 1
• Effect of a High-fat Meal on the Pharmacokinetics of SHR0302 and Mass Balance Study in Healthy SubjectsStatus unknownNCT02892370Phase 1
• Multiple Dose Study of SHR4640 in Healthy SubjectsCompletedNCT02890966Phase 1
• The Efficacy and Safety of Pregabalin Release Tablets for the Treatment of FibromyalgiaStatus unknownNCT02868814Phase 3
• Efficacy and Safety of Pregabalin Sustained Release Tablet for Postherpetic NeuralgiaStatus unknownNCT02868801Phase 3
• Effect of Rifampicin on the Pharmacokinetics of ApatinibCompletedNCT02836821Phase 1
• Effect of Itraconazole on the Pharmacokinetics of ApatinibCompletedNCT02836171Phase 1
• A Clinica Study of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 MutationCompletedNCT02834936Phase 2
• The Pharmacokinetics Study of Single and Multiple Dose of SP2086 in Healthy VolunteersStatus unknownNCT02826044Phase 1
• The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes PatientsStatus unknownNCT02822534Phase 1
• the Food Effect Pharmacokinetic, Material Balance and Metabolite Identification of SP2086 in Healthy VolunteersStatus unknownNCT02821871Phase 1
• The DDI Study of SP2086 and SimvastatinStatus unknownNCT02817243Phase 1
• The DDI Study of SP2086 and ValsartanStatus unknownNCT02817217Phase 1
• Single Dose Study of SHR4640 in Healthy SubjectsCompletedNCT02815839Phase 1
• The Drug -Drug Interaction of SP2086 and GlyburideCompletedNCT02815787Phase 1
• SP2086 Pharmacokinetic Study in Renal Insufficiency PatientsCompletedNCT02815774Phase 1
• The Metabolite Identification and Material Balance Study of SP2086CompletedNCT02815748Phase 1
• The Drug-drug Interaction of SP2086 and SimvastatinCompletedNCT02815722Phase 1
• The Drug-drug Interaction of SP2086 and ValsartanCompletedNCT02815657Phase 1
• The Drug-drug Interaction of SP2086 and MetforminCompletedNCT02813863Phase 1
• A PhaseⅡ/ Ⅲ Seamless Study to Evaluate Efficacy and Safety of Paracetamol Injection as Adjuvant to Morphine-based Postoperative AnalgesiaCompletedNCT02811991Phase 2/3
• SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung CancerTerminatedNCT02766140Phase 3
• Apatinib Dose Titration in Advanced or Metastatic Gastric CancerCompletedNCT02764268Not applicable
• A Phase I Trial of SHR3162 in Subjects With Advanced Solid TumorsCompletedNCT02759666Phase 1
• A Phase I Trial of HS-10241 in Solid TumorsCompletedNCT02759640Phase 1
• A Phase 1, Randomized, Placebo-controlled, Single & Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Healthy Chinese VolunteersCompletedNCT02750553Phase 1
• A PHASE I, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE DOSE ESCALATION STUDY TO INVESTIGATE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SHR0534 IN HEALTHY VOLUNTEERSCompletedNCT02749097Phase 1
• A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate CancerCompletedNCT02747342Phase 1
• A Study to Evaluate the Safety and Tolerability of Using SHR-1210 by Advanced Solid Tumor SubjectsCompletedNCT02742935Phase 1
• A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 in Patients With Advanced MelanomaCompletedNCT02738489Phase 1
• A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Solid Tumor SubjectsCompletedNCT02721589Phase 1
• A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer PatientsStatus unknownNCT02691975Phase 1/2
• A Study of SHR6390 in Advanced Solid Tumor PatientsCompletedNCT02684266Phase 1
• A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma PatientsStatus unknownNCT02671513Phase 1
• Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) PatientsStatus unknownNCT02665910Phase 1
• Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High TriglyceridesStatus unknownNCT02625870Phase 3
• Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) PatientsStatus unknownNCT02614846Phase 1
• A Phase I Study of Fluzoparib in Patient With Advanced Solid MalignanciesCompletedNCT02575651Phase 1

← Jiangsu HengRui Medicine Co., Ltd. overview and focus areas